This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: University of Ghent, Vib Vzw. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 505 
2 out of 238 
Years Active: 2022-2026
Title: José Van Der Heyden: Innovator in Therapeutic Antibodies
Introduction
José Van Der Heyden is a notable inventor based in Munte, Belgium. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on antibodies. His research focuses on the development of agents that bind to CD20, which are crucial in the treatment of various diseases.
Latest Patents
José Van Der Heyden holds 1 patent for his invention titled "CD20 binding single domain antibodies." This patent relates to agents that bind CD20 and their application as therapeutic agents. The patent also discusses pharmaceutical compositions that include these CD20 binding agents, emphasizing their potential use in treating a range of diseases.
Career Highlights
Throughout his career, José has worked with various organizations, including Vib Vzw and Universiteit Gent. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
José has collaborated with notable colleagues such as Jan Tavernier and Anje Cauwels. These partnerships have enriched his work and fostered innovation in the field of therapeutic antibodies.
Conclusion
José Van Der Heyden is a distinguished inventor whose work on CD20 binding antibodies has the potential to impact therapeutic treatments significantly. His contributions to the field highlight the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile